9 April 2018
REPORT RECOMMENDS BETTER ACCESS TO NEEDLE AND SYRINGE PROGRAMS TO COMBAT BLOOD BORNE VIRUSES
The Australian Injecting and Illicit Drug Users League (AIVL) is today releasing a new report on Needle and Syringe
Programs (NSPs) in Australia, with a view to enhancing access for priority populations and reducing the impact of blood
borne viruses (BBVs) in Australia.
“The report looks at the pros and cons of different types of NSPs currently operating around the country and goes on to
make recommendations about ways to increase access and coverage. We already knew from previous studies that
investment in NSPs between 2000 and 2009 prevented nearly 97,000 Hepatitis C infections and 32,050 HIV infections –
for every dollar spent on NSPs, more than $4 will be returned in savings to the health systemi
. This new study looks at
ways to enhance the effectiveness of NSPs across the country to address access issues and maximise the public health
benefits,” said Melanie Walker, Chief Executive Officer (CEO) of AIVL.
The full report can be viewed here.